An Early Prospective Study of the Traq™ Device for Characterization of Binocular Ocular Function in Normal Subjects and Subjects With Recent Traumatic Brain Injury

Recruiting

Traq™An Early Prospective Study of the Traq™ Device for Characterization of Binocular Ocular Function in Normal Subjects and Subjects With Recent Traumatic Brain Injury

Sponsor:

Rebiscan, Inc.

Code:

NCT07742878

Conditions

Mild Traumatic Brain Injury, Concussion

Binocular Visual Function

Neuro-Ophthalmology

Saccadic Eye Movements

Eligibility Criteria

Sex: All

Age: 12+

Healthy Volunteers: Accepted

Interventions

Binocular ophthalmic neurodiagnostic device

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-08-05. This information was provided to ClinicalTrials.gov by Rebiscan, Inc. on 2026-08-03.